IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Other Versions of this Article:
IAI.00587-07v1
75/10/4792    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kechichian, T. B.
Right arrow Articles by Del Poeta, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kechichian, T. B.
Right arrow Articles by Del Poeta, M.

 Previous Article  |  Next Article 

Infection and Immunity, October 2007, p. 4792-4798, Vol. 75, No. 10
0019-9567/07/$08.00+0     doi:10.1128/IAI.00587-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Depletion of Alveolar Macrophages Decreases the Dissemination of a Glucosylceramide-Deficient Mutant of Cryptococcus neoformans in Immunodeficient Mice{triangledown} ,{dagger}

Talar B. Kechichian,1 John Shea,1 and Maurizio Del Poeta1,2,3*

Departments of Biochemistry and Molecular Biology,1 Microbiology and Immunology,2 Division of Infectious Diseases, Medical University of South Carolina, Charleston, South Carolina 294253

Received 23 April 2007/ Returned for modification 26 May 2007/ Accepted 19 July 2007

In previous studies we showed that a Cryptococcus neoformans mutant lacking glucosylceramide ({Delta}gcs1) is avirulent and unable to reach the brain when it is administered intranasally into an immunocompetent mouse and is contained in a lung granuloma. To determine whether granuloma formation is key for containment of C. neoformans {Delta}gcs1, we studied the role of C. neoformans glucosylceramide in a T- and NK-cell-immunodeficient mouse model (Tg{varepsilon}26) in which alveolar macrophages (AMs) are not activated and granuloma formation is not expected. The results show that Tg{varepsilon}26 mice infected with {Delta}gcs1 do not produce a lung granuloma and that the {Delta}gcs1 mutant proliferates in the lungs and does disseminate to the brain, although its virulence phenotype is dramatically reduced. Since {Delta}gcs1 can grow only in acidic niches, such as the phagolysosome of AMs, and not in neutral or alkaline environments, such as the extracellular spaces, we hypothesize that in immunodeficient mice {Delta}gcs1 proliferates inside AMs. Indeed, we found that depletion of AMs significantly improved Tg{varepsilon}26 mouse survival and decreased the dissemination of {Delta}gcs1 cells to the central nervous system. Thus, these results suggest that the growth of {Delta}gcs1 in immunodeficient mice is maintained within AMs. This study highlights the hypothesis that AMs may exacerbate C. neoformans infection in conditions in which there is severe host immunodeficiency.


* Corresponding author. Mailing address: Department of Biochemistry and Molecular Biology, Medical University of South Carolina, 173 Ashley Avenue, BSB 503, Charleston, SC 29425. Phone: (843) 792-8381. Fax: (843) 792-8565. E-mail: delpoeta{at}musc.edu

{triangledown} Published ahead of print on 30 July 2007.

{dagger} Supplemental material for this article may be found at http://iai.asm.org/.

Editor: A. Casadevall


Infection and Immunity, October 2007, p. 4792-4798, Vol. 75, No. 10
0019-9567/07/$08.00+0     doi:10.1128/IAI.00587-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.